zolpidem has been researched along with Cognitive Decline in 3 studies
Zolpidem: An imidazopyridine derivative and short-acting GABA-A receptor agonist that is used for the treatment of INSOMNIA.
zolpidem : An imidazo[1,2-a]pyridine compound having a 4-tolyl group at the 2-position, an N,N-dimethylcarbamoylmethyl group at the 3-position and a methyl substituent at the 6-position.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Assimon, MM | 1 |
| Flythe, JE | 1 |
| Burke, SL | 1 |
| Hu, T | 1 |
| Spadola, CE | 1 |
| Li, T | 1 |
| Naseh, M | 1 |
| Burgess, A | 1 |
| Cadet, T | 1 |
| Dinges, DF | 1 |
| Basner, M | 1 |
| Ecker, AJ | 1 |
| Baskin, P | 1 |
| Johnston, SL | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Operational Ground Testing Protocol to Optimize Astronaut Sleep Medication Efficacy and Individual Effects[NCT03526575] | Phase 4 | 34 participants (Actual) | Interventional | 2011-01-10 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for zolpidem and Cognitive Decline
| Article | Year |
|---|---|
Effects of zolpidem and zaleplon on cognitive performance after emergent morning awakenings at Tmax: a randomized placebo-controlled trial.
Topics: Acetamides; Adult; Cognition; Cognitive Dysfunction; Cross-Over Studies; Double-Blind Method; Female | 2019 |
2 other studies available for zolpidem and Cognitive Decline
| Article | Year |
|---|---|
Zolpidem Versus Trazodone Initiation and the Risk of Fall-Related Fractures among Individuals Receiving Maintenance Hemodialysis.
Topics: Accidental Falls; Aged; Cognitive Dysfunction; Dizziness; Drug Prescriptions; Female; Fractures, Bon | 2020 |
Mild cognitive impairment: associations with sleep disturbance, apolipoprotein e4, and sleep medications.
Topics: Aged; Alleles; Anti-Anxiety Agents; Apolipoprotein E4; Cognitive Dysfunction; Female; Genotype; Huma | 2018 |